Multimodal profiling of pro-inflammatory protease activity identifies caspase-1 as a target for lung cancer interception | Science Advances
Systemic inhibition of interleukin-1b (IL-1b) has been shown to reduce the incidence of lung cancer in patients in years after treatment, but knowledge gaps surrounding its activation and role in the tumor microenvironment hinder cancer interception. We ...
